Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1980-09-22
1982-03-30
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
260112B, 424101, 424177, A61K 3900, A61K 39395
Patent
active
043224032
ABSTRACT:
An immune globulin solution suitable for intravenous use is produced by purifying a salt-containing solution of an immune globulin in a number of adsorptive purification steps using an aqueous, humid, amorphous, chemically pure silicic acid of sub-microscopically fine distribution as the adsorption agent. In each step, the adsorption agent is suspended in the solution, the suspension is incubated for 30 to 60 minutes at about 20.degree. C. while being stirred and the adsorption agent is removed. During at least the first purification step the pH of the suspension is at a value of about 6.8.+-.0.05 (20.degree. C.) and during a subsequent purification step the pH of the suspension is at a value of about 6.5.+-.0.05 (20.degree. C.).
REFERENCES:
patent: 3607857 (1971-07-01), Nelson
patent: 4136094 (1979-01-01), Condie
Blutspendedienst der Landesverbande des Deutschen Roten Kreuzes
Bremen Gemeinnutzige G.m.b.H.
Hazel Blondel
LandOfFree
Method for the preparation of an immune globulin solution suitab does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the preparation of an immune globulin solution suitab, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the preparation of an immune globulin solution suitab will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-382332